Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2889307 | 0.93 | POLB (0.49) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL8076306 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL2890516 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL15082405 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL8084223 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL8084202 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL14477954 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL119623 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL14477978 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 | |
| SCHEMBL1283867 | 0.92 | POLB (0.56) | POLBKMT2AMEN1CYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8349215-B2 | Corrosion inhibitors having increased biological degradability and minimized toxicity | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-01-08 | — | — | US | disclosed |
| US-20100283010-A1 | Corrosion Inhibitors Having Increased Biological Degradability And Minimized Toxicity | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-11-11 | — | — | US | disclosed |